Medical Equipment

Leukapheresis Device Market Analysis Covering Growth Drivers And Future Outlook

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Leukapheresis Device Market Progress Between 2026 And 2030?

The leukapheresis device market size has witnessed significant expansion in recent years. Projections indicate it will expand from $0.7 billion in 2025 to $0.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. This growth observed historically can be attributed to several factors including the rising prevalence of leukemia and autoimmune disorders, the increasing adoption of stem cell therapies, continuous advancements in blood cell separation technology, a surge in clinical research activities, and the expansion of hospital-based apheresis services.

The leukapheresis device market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth is driven by several factors, including the increasing demand for portable leukapheresis systems, the incorporation of AI and automation into these devices, the ongoing expansion of biopharmaceutical research, the granting of regulatory approvals for advanced apheresis devices, and a rise in investments directed towards precision medicine. Key trends characterizing this forecast period encompass personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the development of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and advancements in automation and workflow efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

What Significant Factors Are Influencing The Leukapheresis Device Market Expansion?

The increasing occurrence of blood-related disorders is anticipated to fuel the expansion of the leukapheresis device market. Blood-related disorders are medical conditions that impact the structure or functionality of blood cells, leading to complications in oxygen delivery, immune responses, or blood clotting. The growing incidence of these disorders is mainly linked to an aging population, as older individuals are more vulnerable to conditions such as anemia, leukemia, and various hematological issues. Leukapheresis devices play a crucial role in managing these conditions by selectively extracting surplus or abnormal white blood cells from the bloodstream, thereby helping to mitigate symptoms and minimize complications in diseases like leukemia and autoimmune conditions. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that around 19,500 Australians were diagnosed with blood cancer, including leukemia, lymphoma, and myeloma, with nearly 43% incurring significant out-of-pocket treatment costs and 42% requiring over three months off work, emphasizing both the rising incidence and the financial burden on patients and their families compared to previous years. Consequently, the rising prevalence of blood-related disorders is driving the growth of the leukapheresis device market.

Which Segment Categories Are Included In The Leukapheresis Device Market Segment Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

What Trends Are Affecting The Direction Of The Leukapheresis Device Market?

Key companies operating in the leukapheresis device market are prioritizing investments in regional manufacturing to enhance local accessibility to high-quality therapeutic devices and support national healthcare agendas. These regional production commitments contribute to establishing efficient and flexible supply chains, ensuring timely product delivery, reducing dependence on imports, and improving the affordability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, partnered with Terumo Medical Products (Hangzhou) Co., Ltd., a China-based medical technology subsidiary company, to commence localized production in Hangzhou, China. This strategic initiative encompasses the domestic manufacturing of critical leukapheresis products, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are widely employed in China for therapeutic apheresis, stem cell collection, and blood component separation.

Who Are The Active Companies Shaping The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Get The Full Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Is The Leading Market For The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Leukapheresis Device Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795